Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huatan Quyu Jiedu Tongmai Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Xiyuan Hospital of China Academy of Chinese Medical Sciences. It is primarily investigated for the treatment of atherosclerosis and blood-lipid metabolic disorders. The formula is designed based on the TCM principles of resolving phlegm (Huatan), removing blood stasis (Quyu), detoxifying (Jiedu), and unblocking the vessels (Tongmai). Clinical research indicates that the formula may exert its therapeutic effects by modulating gut microbial metabolites and influencing the distribution of monocyte subsets, thereby reducing systemic inflammation and slowing the progression of atherosclerotic plaques.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huatan Quyu Jiedu Tongmai Formula.